Entero Therapeutics, Inc. Annual Return On Equity in % from 2016 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Entero Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2016 to 2023.
  • Entero Therapeutics, Inc. Return On Equity for the quarter ending March 31, 2024 was -103 %, a 131% decline year-over-year.
  • Entero Therapeutics, Inc. annual Return On Equity for 2023 was -603 %, a 337% decline from 2022.
  • Entero Therapeutics, Inc. annual Return On Equity for 2022 was 255 %.
  • Entero Therapeutics, Inc. annual Return On Equity for 2021 was -3.52K %, a 268% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -603 -858 -337% Jan 1, 2023 Dec 31, 2023
2022 255 +3.78K Jan 1, 2022 Dec 31, 2022
2021 -3.52K -2.57K -268% Jan 1, 2021 Dec 31, 2021
2020 -956 -506 -112% Jan 1, 2020 Dec 31, 2020
2019 -450 -161 -55.8% Jan 1, 2019 Dec 31, 2019
2018 -289 +131 +31.2% Jan 1, 2018 Dec 31, 2018
2017 -420 -665 -271% Jan 1, 2017 Dec 31, 2017
2016 245 Jan 1, 2016 Dec 31, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.